يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"O'Brien, Mary"', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)

    المؤلفون: O'Brien, Mary E. R., Gaafar, Rabab, Hasan, Baktiar, Menis, Jessica, Cufer, Tanja, Popat, Sanjay, Woll, Penella J., Surmont, Veerle, Georgoulias, Vassilis, Montes, Ana, Blackhall, Fiona, Hennig, Ivo, Schmid-Bindert, Gerald, Baas, Paul

    المساهمون: O'Brien, Mary E. R., Gaafar, Rabab, Hasan, Baktiar, Menis, Jessica, Cufer, Tanja, Popat, Sanjay, Woll, Penella J., Surmont, Veerle, Georgoulias, Vassili, Montes, Ana, Blackhall, Fiona, Hennig, Ivo, Schmid-Bindert, Gerald, Baas, Paul

    مصطلحات موضوعية: Advanced, Double blind, Maintenance, NSCLC, Pazopanib, Phase III, Adult, Aged, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Non-Small-Cell Lung, Disease Progression, Disease-Free Survival, Double-Blind Method, Female, Human, Kaplan-Meier Estimate, Lung Neoplasm, Maintenance Chemotherapy, Male, Middle Aged, Protein Kinase Inhibitor, Pyrimidine, Sulfonamide, Oncology, Cancer Research

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26074395; info:eu-repo/semantics/altIdentifier/wos/WOS:000357658900004; volume:51; issue:12; firstpage:1511; lastpage:1528; numberofpages:18; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11577/3290294Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84936847322; http://www.journals.elsevier.com/european-journal-of-cancerTest/

    الإتاحة: https://doi.org/10.1016/j.ejca.2015.04.026Test
    http://hdl.handle.net/11577/3290294Test
    http://www.journals.elsevier.com/european-journal-of-cancerTest/

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation

    المؤلفون: Hasan, Baktiar, Greillier, Laurent, Pallis, Athanasios, Menis, Jessica, Gaafar, Rabab, Sylvester, Richard, Fennell, Dean A., Baas, Paul, Surmont, Veerle, Van Meerbeeck, Jan P., O'Brien, Mary E. R.

    المساهمون: Hasan, Baktiar, Greillier, Laurent, Pallis, Athanasio, Menis, Jessica, Gaafar, Rabab, Sylvester, Richard, Fennell, Dean A., Baas, Paul, Surmont, Veerle, Van Meerbeeck, Jan P., O'Brien, Mary E. R.

    مصطلحات موضوعية: Keywords Progression free survival rates at 9 and 18 weeks (PFSR-9 and 18), Malignant pleural mesothelioma (MPM), Overall survival (OS) prediction, Response rate, Adult, Aged, 80 and over, Disease-Free Survival, Europe, Female, Human, Lung Neoplasm, Male, Mesothelioma, Middle Aged, Pleural Neoplasm, Prognosi, Reproducibility of Result, Survival Analysi, Treatment Outcome, Young Adult, Oncology, Cancer Research

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25155251; info:eu-repo/semantics/altIdentifier/wos/WOS:000342701500004; volume:50; issue:16; firstpage:2771; lastpage:2782; numberofpages:12; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11577/3290295Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84925248655; http://www.journals.elsevier.com/european-journal-of-cancerTest/

    الإتاحة: https://doi.org/10.1016/j.ejca.2014.07.020Test
    http://hdl.handle.net/11577/3290295Test
    http://www.journals.elsevier.com/european-journal-of-cancerTest/

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث